Effects of single-dose betrixaban on the QT interval in volunteers

Trial Profile

Effects of single-dose betrixaban on the QT interval in volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Mar 2013

At a glance

  • Drugs Betrixaban (Primary) ; Moxifloxacin
  • Indications Bacterial infections; Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism
  • Focus Adverse reactions
  • Most Recent Events

    • 20 Mar 2013 New trial record
    • 11 Mar 2013 Results presented at the 62nd Annual Scientific Session of the American College of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top